SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

26 May 2025 Evaluate
The Revenue for the quarter ended  March 2025 of Rs. 1940.40 millions grew by 10.78 % from Rs. 1751.60 millions.The Company has registered profit of Rs. 147.90  millions for the quarter ended March 2025, a growth of 18.23%  over Rs. 125.10 millions millions achieved in the corresponding quarter of last year.OP of the company witnessed a marginal growth to 293.20 millions from 251.90 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1940.40 1751.60 10.78 6394.60 5752.10 11.17 6394.60 5752.10 11.17
Other Income 67.70 39.10 73.15 207.80 113.20 83.57 207.80 113.20 83.57
PBIDT 293.20 251.90 16.40 907.70 722.00 25.72 907.70 722.00 25.72
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 293.20 251.90 16.40 1006.80 722.00 39.45 1006.80 722.00 39.45
Depreciation 44.90 57.20 -21.50 216.20 255.50 -15.38 216.20 255.50 -15.38
PBT 248.30 194.70 27.53 790.60 466.50 69.47 790.60 466.50 69.47
TAX 100.40 69.60 44.25 265.10 161.50 64.15 265.10 161.50 64.15
Deferred Tax 18.30 15.80 15.82 46.50 39.30 18.32 46.50 39.30 18.32
PAT 147.90 125.10 18.23 525.50 305.00 72.30 525.50 305.00 72.30
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 15.11 14.38 5.07 14.19 12.55 13.09 14.19 12.55 13.09

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×